Company Summary

Janssen Pharmaceutical was set up on Wednesday the 31st of December 1980. Their current partial address is Cork, and the company status is Normal. The company's current directors have been the director of 41 other Irish companies between them; 19 of which are now closed. Janssen Pharmaceutical has 2 shareholders.

Company Name:Janssen Pharmaceutical
Company Status:NORMAL
Company Address:Little Island Industrial Estate,
Co. Cork.,
Little Island,Cork
Telephone:+353 (0)1 620 2300
Website:www.janssen.ie
Key Executive:Mr O'Leary
Company Size:Log-In To View
Disclaimer Other Details
Please note the contact details displayed above are collected from a variety of public sources and are appended to this report for your convenience. As they are non-CRO data, we can not vouch for their accuracy or timeliness. To update contact details on this company simply email us.

Key Contact Profile

Mr O'Leary is a Company Director of Janssen Pharmaceutical since 2018 and a listed Director of 33 other companies.

Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.

Similar Companies - Create a marketing list of similar companies

Latest Updates

The latest documents filed with the Companies Registration Office for Janssen Pharmaceutical (which can include the Account Details) are listed below.

CRO DocumentEffective DateReceived By CROView Now
G1P - SPECIAL RESOLUTION30/11/202010/12/2020Join Up
B7 NOTICE OF CONSOLIDATION, DIVISION, CONVERSION30/11/202010/12/2020Join Up
B1 ANNUAL RETURN30/09/201916/12/2019Join Up
Account details30/09/201916/12/2019Join Up
B18A - REGISTRATION OF A LOCAL OFFERING DOCUMENT22/02/201919/02/2019Join Up
THIS COMPANY HAS 181 OTHER DOCS »

View CRO company documents and company reports any Irish company or business with ease.

Credit Report

View the Latest Credit Report and Credit Limit on Janssen Pharmaceutical.

Company Status:Normal
Latest Credit Movement:
Date of Last Movement:10/02/2020
Latest Accounts Filed:16/12/2019
Report Based on Accounts:30/12/2018
Next Set of Accounts Due:30/09/2020
Overdue:No
Credit Score:Join-Up to View

Full Credit Rating

To View the latest Credit Rating or Credit Limit on Janssen Pharmaceutical simply click 'Log-In' or 'Join-Up' below.

Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.

Directors & Owners

Satisfy due diligence requirments on Janssen Pharmaceutical in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Janssen Pharmaceutical and Anti-Money Laundering checks (AML checks) on Janssen Pharmaceutical

Directors details are available to logged in users.

Ownership Structure

Company Type:ULC - Private Unlimited Company (Licenced Company)
Number of Shareholders:2

Compliance

Log-in now to run Due Diligence checks and Compliance checks on Janssen Pharmaceutical or click Join-up to get started.

Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.

Ask Us A Question...?

What's New In 2021

12/01/2021

As always our mission for 2021 is to innovate and continue to bring you the best and most up-to-date insights available

Read More »

Brexit Preparation: Credit Reports Available For Over 4m UK Companies

21/12/2020

Confidence has been reduced and uncertainty has increased, forcing Irish businesses to implement many different preparations.

Read More »

Company Start-ups Sees Large Up-Swing In November

15/12/2020

As we head towards the end of a turbulent year for Irish business, a positive sign of a possible recovery in company start-ups is appearing

Read More »

The Future Of Banking Is Open - But What Is 'Open Banking'

15/12/2020

Open Banking is a term many might not have heard of but it won't be the last time you hear of this new initiative that is set to transform the way we use banking and financial services

Read More »